Benserazide hydrochloride is the hydrochloride salt form of benserazide, a peripheral aromatic-L-amino-acid decarboxylase (DOPA decarboxylase) inhibitor. It is used as a pharmaceutical raw material in combination with levodopa for managing parkinsonism, as it increases levodopa availability to the central nervous system by preventing its peripheral conversion to dopamine.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 14919-77-8
Leucovorin calcium
pharmaceutical raw material
{4-[(2S)-2-[(2S)-2-(1-amino-3,6,9,12-tetraoxapentadecan-15-amido)-3-methylbutanamido]-5-(carbamoylamino)pentanamido]phenyl}methyl N-[(1S)-1-{[(1S)-1-{[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-2-{[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]carbamoyl}-1-methoxy-2-methyleth
pharmaceutical raw material
Cidofovir dihydrate
pharmaceutical raw material
N-(4-(2-Aminoacetyl)-5-methoxy-2-phenoxyphenyl)methanesulfonamide hydrochloride
pharmaceutical raw material
2-amino-3-hydroxy-N'-[(2,3,4-trihydroxyphenyl)methyl]propanehydrazide;hydrochloride
ULFCBIUXQQYDEI-UHFFFAOYSA-N
C1=CC(=C(C(=C1CNNC(=O)C(CO)N)O)O)O.Cl